Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2026-03-04 @ 6:59 AM
Study NCT ID:
NCT02705820
Status:
COMPLETED
Last Update Posted:
2025-06-17
First Post:
2016-02-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Switch Maintenance Pembrolizumab in Patients With NSCLC After First Line Platinum Doublet Chemotherapy
Sponsor:
Organization: